Exploring Patient Experiences: CSII vs MDII for T1DM Management
VerifiedAdded on 2022/10/06
|12
|4638
|3
Report
AI Summary
This research proposal outlines a qualitative study comparing the experiences of children and adolescents with Type 1 Diabetes Mellitus (T1DM) using Continuous Subcutaneous Insulin Infusion (CSII) and Multiple Daily Insulin Injections (MDII). The study aims to explore patient perspectives on burden of care, cost of care, and feasibility of usage of these two insulin delivery methods. The proposal includes a literature review summarizing existing research, highlighting the benefits of CSII in terms of glycemic control and cardiovascular health, while acknowledging the higher costs and technological demands associated with CSII. The proposed methodology involves semi-structured interviews with patients aged 8-19 years who have been using either CSII or MDII for at least three months. A simple random sampling method will be employed to select participants. Data will be collected through interviews using a validated questionnaire and analyzed to compare patient experiences. The study intends to contribute to a better understanding of patient preferences and inform clinical decision-making in T1DM management.
Contribute Materials
Your contribution can guide someone’s learning journey. Share your
documents today.